236 related articles for article (PubMed ID: 10616002)
1. Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis.
Cook AD; Stockman A; Brand CA; Tait BD; Mackay IR; Muirden KD; Bernard CC; Rowley MJ
Arthritis Rheum; 1999 Dec; 42(12):2569-76. PubMed ID: 10616002
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
3. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
[TBL] [Abstract][Full Text] [Related]
4. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
5. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
[TBL] [Abstract][Full Text] [Related]
6. Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value.
Hong GH; Park MH; Takeuchi F; Oh MD; Song YW; Nabeta H; Nakano K; Ito K; Park KS
J Rheumatol; 1996 Oct; 23(10):1699-703. PubMed ID: 8895143
[TBL] [Abstract][Full Text] [Related]
7. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition.
Pascual M; Nieto A; López-Nevot MA; Ramal L; Matarán L; Caballero A; Alonso A; Martín J; Zanelli E
Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460
[TBL] [Abstract][Full Text] [Related]
9. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
10. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
[TBL] [Abstract][Full Text] [Related]
11. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope.
Malysheva O; Pierer M; Wagner U; Wahle M; Wagner U; Baerwald CG
Ann Rheum Dis; 2008 Dec; 67(12):1759-64. PubMed ID: 18267980
[TBL] [Abstract][Full Text] [Related]
12. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
[TBL] [Abstract][Full Text] [Related]
13. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.
Reviron D; Perdriger A; Toussirot E; Wendling D; Balandraud N; Guis S; Semana G; Tiberghien P; Mercier P; Roudier J
Arthritis Rheum; 2001 Mar; 44(3):535-40. PubMed ID: 11263767
[TBL] [Abstract][Full Text] [Related]
14. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
15. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity to native type II collagen--a distinct genetic subset of rheumatoid arthritis.
Klimiuk PS; Clague RB; Grennan DM; Dyer PA; Smeaton I; Harris R
J Rheumatol; 1985 Oct; 12(5):865-70. PubMed ID: 3878877
[TBL] [Abstract][Full Text] [Related]
18. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
[TBL] [Abstract][Full Text] [Related]
19. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).
Barrera P; Balsa A; Alves H; Westhovens R; Maenaut K; Cornélis F; Fritz P; Bardin T; Ceu Maia M; Lopes-Vaz A; Pascual Salcedo D; de la Concha E; Radstake T; van de Putte LB; Migliorini P; Prudhomme JF; Charron D; Spyropoulou M; Mendes A; Spaepen M; Martinez M; Stavropoulos C;
J Rheumatol; 2001 May; 28(5):968-74. PubMed ID: 11361224
[TBL] [Abstract][Full Text] [Related]
20. No support for HLA-DQ encoded susceptibility in rheumatoid arthritis.
de Vries N; van Elderen C; Tijssen H; van Riel PL; van de Putte LB
Arthritis Rheum; 1999 Aug; 42(8):1621-7. PubMed ID: 10446860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
